Ambient Artificial Intelligence Scribes in Oncology: Adoption, Feasibility, Acceptability, and Appropriateness.

IF 2.2 2区 医学 Q4 MEDICAL INFORMATICS
Applied Clinical Informatics Pub Date : 2025-08-01 Epub Date: 2025-09-03 DOI:10.1055/a-2662-0740
Abigail E Baldwin-Medsker, Susan Chimonas, Suryan P Goyal, Adam J Watson, Maclain R Damstrom, Gilad J Kuperman, Tiffany Traina, Benjamin R Roman, Peter D Stetson, Allison Lipitz-Snyderman
{"title":"Ambient Artificial Intelligence Scribes in Oncology: Adoption, Feasibility, Acceptability, and Appropriateness.","authors":"Abigail E Baldwin-Medsker, Susan Chimonas, Suryan P Goyal, Adam J Watson, Maclain R Damstrom, Gilad J Kuperman, Tiffany Traina, Benjamin R Roman, Peter D Stetson, Allison Lipitz-Snyderman","doi":"10.1055/a-2662-0740","DOIUrl":null,"url":null,"abstract":"<p><p>Hospitals are looking to AI and other innovative applications to help alleviate provider burden and dissatisfaction associated with clinical documentation in oncology. Ambient artificial intelligence (AI) scribes are a promising technology to address these issues. However, they generally have not been optimized for oncology. This study aimed to evaluate an ambient AI scribe application with oncology providers to determine opportunities and potential challenges.This prospective pilot study of a scribe application was conducted over 4 months at a high-volume cancer center in New York City. Qualitative (interviews) and quantitative (surveys and utilization) data were collected to assess adoption, feasibility, acceptability, and appropriateness. The analysis included descriptive statistics and thematic content analysis.Thirty-one providers were included across oncology specialties. Twenty-five providers used the application at least once; of these, 18 completed a survey and 21 completed an interview. Providers used the application in 620 (13.9%) out of 4,449 in-person outpatient visits. Out of 18 survey respondents, 17 (94%) indicated they used the AI-drafted content at least sometimes, demonstrating feasibility. For acceptability, 11 (61%) indicated a moderate, strong, or very strong desire for continued access to the technology. All providers interviewed advocated for continued investment in ambient technology. Metrics around appropriateness showed variability based on its accuracy in capturing complex clinical scenarios and in the types of patients the technology was used with. For example, providers used the technology for 21.1% of new visits but only 12.2% of follow-up visits.This study demonstrated the potential for ambient AI scribes to be useful in oncology. Future research should evaluate the use of this technology at scale as it may realize workflow efficiencies and improve the clinical documentation process.</p>","PeriodicalId":48956,"journal":{"name":"Applied Clinical Informatics","volume":"16 4","pages":"995-1004"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12408117/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Clinical Informatics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2662-0740","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/3 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

Hospitals are looking to AI and other innovative applications to help alleviate provider burden and dissatisfaction associated with clinical documentation in oncology. Ambient artificial intelligence (AI) scribes are a promising technology to address these issues. However, they generally have not been optimized for oncology. This study aimed to evaluate an ambient AI scribe application with oncology providers to determine opportunities and potential challenges.This prospective pilot study of a scribe application was conducted over 4 months at a high-volume cancer center in New York City. Qualitative (interviews) and quantitative (surveys and utilization) data were collected to assess adoption, feasibility, acceptability, and appropriateness. The analysis included descriptive statistics and thematic content analysis.Thirty-one providers were included across oncology specialties. Twenty-five providers used the application at least once; of these, 18 completed a survey and 21 completed an interview. Providers used the application in 620 (13.9%) out of 4,449 in-person outpatient visits. Out of 18 survey respondents, 17 (94%) indicated they used the AI-drafted content at least sometimes, demonstrating feasibility. For acceptability, 11 (61%) indicated a moderate, strong, or very strong desire for continued access to the technology. All providers interviewed advocated for continued investment in ambient technology. Metrics around appropriateness showed variability based on its accuracy in capturing complex clinical scenarios and in the types of patients the technology was used with. For example, providers used the technology for 21.1% of new visits but only 12.2% of follow-up visits.This study demonstrated the potential for ambient AI scribes to be useful in oncology. Future research should evaluate the use of this technology at scale as it may realize workflow efficiencies and improve the clinical documentation process.

环境人工智能抄写员在肿瘤学:采用,可行性,可接受性和适当性。
医院正在寻求人工智能和其他创新应用程序来帮助减轻提供者的负担和与肿瘤学临床文件相关的不满。环境人工智能(AI)抄写器是解决这些问题的一项很有前途的技术。然而,它们通常还没有被优化用于肿瘤学。本研究旨在评估肿瘤供应商的环境人工智能应用,以确定机遇和潜在挑战。这项前瞻性的试点研究是在纽约市的一个高容量癌症中心进行的,为期4个月。收集定性(访谈)和定量(调查和利用)数据来评估采用、可行性、可接受性和适当性。分析包括描述性统计和专题内容分析。31名医生被纳入肿瘤学专业。有25家供应商至少使用过该应用程序一次;其中18人完成了调查,21人完成了访谈。在4449次面对面门诊就诊中,有620次(13.9%)使用了该应用程序。在18个调查对象中,17个(94%)表示他们至少有时使用人工智能起草的内容,证明了可行性。在可接受性方面,11人(61%)表示对继续使用该技术有中等、强烈或非常强烈的愿望。所有受访的供应商都主张继续投资环境技术。在捕捉复杂临床场景和使用该技术的患者类型的准确性基础上,适当性指标显示出可变性。例如,医疗服务提供者在21.1%的新就诊中使用了该技术,但在后续就诊中只使用了12.2%。这项研究证明了环境人工智能转录器在肿瘤学中的应用潜力。未来的研究应该评估这种技术的大规模应用,因为它可以提高工作流程的效率,并改善临床记录过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Applied Clinical Informatics
Applied Clinical Informatics MEDICAL INFORMATICS-
CiteScore
4.60
自引率
24.10%
发文量
132
期刊介绍: ACI is the third Schattauer journal dealing with biomedical and health informatics. It perfectly complements our other journals Öffnet internen Link im aktuellen FensterMethods of Information in Medicine and the Öffnet internen Link im aktuellen FensterYearbook of Medical Informatics. The Yearbook of Medical Informatics being the “Milestone” or state-of-the-art journal and Methods of Information in Medicine being the “Science and Research” journal of IMIA, ACI intends to be the “Practical” journal of IMIA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信